title: The risk of infection associated with tumor necrosis factor alpha antagonists: making sense of epidemiologic evidence.
authors.affiliation: Brigham and Women's Hospital, Division of Rheumatology, Immunology and Allergy, and Harvard Medical School, Boston, Massachusetts 02115, USA. dhsolomon@partners.org
authors.forename: Daniel H
authors.initials: DH
authors.lastname: Solomon
authors.forename: Mark
authors.initials: M
authors.lastname: Lunt
authors.forename: Sebastian
authors.initials: S
authors.lastname: Schneeweiss
mesh_terms: D015340:Epidemiologic Research Design; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects* / Q000276:immunology; D007239:Infections / Q000139:chemically induced* / Q000453:epidemiology; D017891:Pharmacoepidemiology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha